Eastman Chemical (NYSE:EMN) Updates Q3 2025 Earnings Guidance

Key Points

• Eastman Chemical updated its Q3 2025 earnings guidance, projecting an EPS of 1.250, significantly below the consensus estimate of 1.915.
• Recent analyst ratings reflect mixed sentiments; while Wells Fargo lowered their price target to $90.00, Royal Bank of Canada upgraded it to $91.00.
• Eastman Chemical's stock is currently trading at $72.72, marking a 1.0% decline and is below the company's 1-year high of $114.50.

Eastman Chemical (NYSE:EMN - Get Free Report) updated its third quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 1.250-1.250 for the period, compared to the consensus earnings per share estimate of 1.915. The company issued revenue guidance of -.

Eastman Chemical Trading Up 4.2%

EMN traded up $2.48 during midday trading on Monday, reaching $61.27. 738,483 shares of the company's stock traded hands, compared to its average volume of 1,537,567. The firm has a fifty day moving average of $77.71 and a two-hundred day moving average of $84.48. The stock has a market capitalization of $7.07 billion, a price-to-earnings ratio of 8.56, a P/E/G ratio of 1.69 and a beta of 1.21. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.72 and a quick ratio of 0.79. Eastman Chemical has a 52 week low of $56.78 and a 52 week high of $114.50.

Eastman Chemical (NYSE:EMN - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The basic materials company reported $1.60 EPS for the quarter, missing analysts' consensus estimates of $1.72 by ($0.12). The business had revenue of $2.29 billion for the quarter, compared to the consensus estimate of $2.32 billion. Eastman Chemical had a net margin of 8.96% and a return on equity of 15.29%. The company's revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the previous year, the company earned $2.15 EPS. On average, equities analysts anticipate that Eastman Chemical will post 8.55 earnings per share for the current fiscal year.

Analyst Ratings Changes

EMN has been the subject of a number of recent analyst reports. The Goldman Sachs Group lowered their price target on Eastman Chemical from $112.00 to $87.00 and set a "neutral" rating for the company in a research report on Monday, April 28th. KeyCorp reduced their target price on Eastman Chemical from $106.00 to $93.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $76.00 target price (down previously from $112.00) on shares of Eastman Chemical in a report on Monday, April 28th. UBS Group reduced their target price on Eastman Chemical from $107.00 to $101.00 and set a "buy" rating on the stock in a report on Wednesday, July 9th. Finally, Morgan Stanley reduced their target price on Eastman Chemical from $125.00 to $115.00 and set an "overweight" rating on the stock in a report on Monday, April 28th. Six analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $93.62.

Institutional Trading of Eastman Chemical

Several hedge funds and other institutional investors have recently made changes to their positions in EMN. Brighton Jones LLC purchased a new stake in shares of Eastman Chemical in the 4th quarter worth approximately $202,000. United Services Automobile Association purchased a new stake in Eastman Chemical during the 1st quarter valued at $252,000. Focus Partners Wealth boosted its stake in Eastman Chemical by 28.4% during the 1st quarter. Focus Partners Wealth now owns 6,403 shares of the basic materials company's stock valued at $564,000 after purchasing an additional 1,415 shares during the last quarter. Integrated Wealth Concepts LLC boosted its stake in Eastman Chemical by 185.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 6,686 shares of the basic materials company's stock valued at $589,000 after purchasing an additional 4,345 shares during the last quarter. Finally, NewEdge Advisors LLC boosted its stake in shares of Eastman Chemical by 2.6% in the 1st quarter. NewEdge Advisors LLC now owns 7,310 shares of the basic materials company's stock worth $644,000 after buying an additional 183 shares during the last quarter. Hedge funds and other institutional investors own 83.65% of the company's stock.

Eastman Chemical Company Profile

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.